Excision and autogenous revascularization of an infected aortic stent graft resulting from a urinary tract infection

Abstract

Commerically manufactured stent graft devices for the treatment of abdominal aortic aneurysm (AAA) were approved by the US Food and Drug Administration in 1999. Since that time, these devices have been increasingly used to treat AAAs in the United States. Because these devices are packaged within a sterile sheath delivery system, thereby shielding the graft material from potential contamination at the time of implantation, it is generally held that these devices are less susceptible to prosthetic infection than are conventionally placed aortic grafts. This report describes a case of prosthetic infection of an aortic stent graft that became infected because of a urinary tract infection.